AnalystsChris LewisChris Lewis's Stock Forecasts
AnalystsChris Lewis
Analyst Ranking
Top 23%
#1104 out of 4875 analysts
Average Return
+77.82%
Win Rate
88%7 out of 8
Risk vs Reward
Poor
Good
Chris Lewis's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Axogen IncAXGN | +234.52% | $9.85 | $32.95 | 2017-03-06 - 2018-03-06 | Strong Buy |
Iradimed CorpIRMD | +133.50% | $9.85 | $23.00 | 2017-07-31 - 2018-07-31 | Strong Buy |
Exact Sciences CorpEXAS | +98.28% | $22.69 | $44.99 | 2017-02-22 - 2018-02-22 | Strong Buy |
Iradimed CorpIRMD | +75.16% | $14.25 | $24.96 | 2017-10-31 - 2018-10-31 | Strong Buy |
Cutera IncCUTRQ | +56.76% | $25.90 | $40.60 | 2017-06-26 - 2018-06-26 | Strong Buy |
Chris Lewis Analyst Color
Get additional color on Chris Lewis's coverage of popular stocks
Chris Lewis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Apollo Endosurgery IncAPEN | 3 | Hold | N/A | N/A | Downgrades | 7 years ago |
Cognyte Software LtdCGNT | 1 | Strong Buy | $4.00 | N/A | Reinstates | 8 years ago |
Iradimed CorpIRMD | 2 | Strong Buy | $16.00 | N/A | Reinstates | 8 years ago |
Cutera IncCUTRQ | 1 | Strong Buy | $32.00 | N/A | Initiates Coverage On | 8 years ago |
Axogen IncAXGN | 1 | Strong Buy | $14.50 | N/A | Initiates Coverage On | 8 years ago |
Exact Sciences CorpEXAS | 1 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Iridex CorpIRIX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.